Antibody-mediated rejection
Authors:
- Glen P. WestallGWGlen P. Westall
- Miranda A. ParaskevaMPMiranda A. Paraskeva
- Greg I. SnellGSGreg I. Snell
- 1 October 2015
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 20 (5) , 492-497
Abstract
Pulmonary antibody-mediated rejection (AMR) while contributing to acute and chronic allograft dysfunction remains a diagnostic and therapeutic challenge. The diagnostic tenets upon which AMR is defined will be reviewed in the light of recent studies. The introduction of solid phase assays such as the Luminex platform has provided a wealth of quantitative data on the presence of anti-human leukocyte antigen (HLA) donor-specific antibodies (DSA). Further studies are required to better define the relationship of circulating DSA and activation of proinflammatory immune pathways that result in allograft dysfunction. The limitations of C4d staining in defining AMR are highlighted from recent studies in lung transplantation and from the 2013 Banff meeting on renal transplantation. The current challenge to the lung transplant community is to agree on a working definition of pulmonary AMR. Only then can we better appreciate the epidemiology, clinical phenotypes, and treatment of AMR.Keywords
This publication has 30 references indexed in Scilit:
- First report on the antibody verification of HLA-DR, HLA-DQ and HLA-DP epitopes recorded in the HLA Epitope RegistryHuman Immunology, 2014
- Pre-transplant donor HLA-specific antibodies: Characteristics causing detrimental effects on survival after lung transplantationThe Journal of Heart and Lung Transplantation, 2014
- HLA epitope based matching for transplantationTransplant Immunology, 2014
- Update of the HLA class I eplet database in the website based registry of antibody‐defined HLA epitopesTissue Antigens, 2014
- Antibody Desensitization Therapy in Highly Sensitized Lung Transplant CandidatesAmerican Journal of Transplantation, 2014
- Complement-Binding Anti-HLA Antibodies and Kidney-Allograft SurvivalNew England Journal of Medicine, 2013
- Lung Transplantation in Patients with Pretransplantation Donor-Specific Antibodies Detected by Luminex AssayTransplantation, 2013
- Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in TransplantationTransplantation, 2013
- HLA-Specific Antibodies are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft DysfunctionAmerican Journal of Transplantation, 2004
- HLA-Specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejectionThe Journal of Heart and Lung Transplantation, 2004